Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

At BiOS SCHOTT to Present a Variety of Glass Substrates for Use in Biotechnology

Published: Friday, January 31, 2014
Last Updated: Thursday, January 30, 2014
Bookmark and Share
Specialty glass and in-house micro-structuring technology for top quality substrates.

The international technology group and specialty glass expert SCHOTT offers a broad portfolio of glass substrates with customized features for use in the growing field of life sciences, for instance, microfluidics and next-generation sequencing.

The glass types D263® T eco, MEMPax®, BOROFLOAT® and B270®i offer the customer a choice between different product characteristics and material thicknesses to best suit the needs of the individual applications. These products as well as NEXTERION® substrates will be on display at BiOS from February 1 to 2 (SCHOTT booth #8642).

Microfluidics is on its way to becoming a main stream enabling technology for fields as diverse as medical diagnostics, life science research or drug delivery and synthesis. There are many applications which rely on highly complex microfluidic chips, and these chips can only be produced from high quality substrates.

In such cases, polymer-based chips fail to provide the required level of precision or sophistication and the costs of silicon chips are very high. Therefore, glass-based chips are ideally suited for applications which rely on chip complexity such as high density or integrated sensing functionalities at a competitive price level.

“Not only do we at SCHOTT offer a portfolio of different well-known glass products for a maximum variety of uses, but we have also developed our own micro-structuring technology which allows us to apply structures under 100 microns in diameter to the glass substrates. We can process the borosilicate glass types D263® T eco, MEMPax® and BOROFLOAT® as well as the highly transparent ultra-white crown glass B 270® i,” says Andreas Haedrich, Sales Director EMEA for SCHOTT Advanced Optics.

NEXTERION® substrates pre-scribed to final format
SCHOTT now also offers its NEXTERION® slides and wafers for biotech applications pre-scribed to the final format, allowing for the substrates to be processed first and then efficiently broken to size in the final step. This results in easier handling and cost reductions especially for high quantities. Microarray applications are the foundation of NEXTERION® substrates, however, a diverse portfolio with customized solutions for life science and diagnostics complement the standard product range.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Schott Looks to KNF Flodos for Pump Technology
Schott uses KNF Flodos’ Pumps in the development of analytical instruments.
Monday, May 29, 2006
Scientific News
Futuristic Brain Probe Allows for Wireless Control of Neurons
NIH-funded scientists developed an ultra-thin, minimally invasive device for controlling brain cells with drugs and light.
Microfluidic Device Mixes And Matches DNA For Synthetic Biology
Researchers have developed a microfluidic device that quickly builds packages of DNA and delivers them into bacteria or yeast for further testing.
Artificial Pancreas Controls Diabetes
Scientists are reporting the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar, or glucose, level and can automatically release insulin as needed.
Major Step for Implantable Drug-Delivery Device
MIT spinout signs deal to commercialize microchips that release therapeutics inside the body.
Smart Insulin Patch Could Replace Painful Injections for Diabetes
A joint effort between diabetes doctors and biomedical engineers could revolutionize how people with diabetes keep their blood sugar levels in check.
The Secrets of Secretion
Researchers have hacked nature's blueprints to create a new technology that could have broad-reaching impact on drug delivery systems and self-healing and anti-fouling materials.
New Tool on Horizon for Surgeons Treating Cancer Patients
Surgeons could know while their patients are still on the operating table if a tissue is cancerous, according to researchers.
Heartbeat on a Chip Could Improve Pharmaceutical Tests
A gravity-powered chip that can mimic a human heartbeat outside the body could advance pharmaceutical testing and open new possibilities in cell culture because it can mimic fundamental physical rhythms.
Unravelling the Mysteries of Carbonic Acid
Researchers have shown how gaseous carbon dioxide molecules are solvated by water to initiate the proton transfer chemistry that produces carbonic acid and bicarbonate.
Injectable Device Delivers Nano-View of the Brain
A team of researchers has developed a method of fabricating nanoscale electronic scaffolds that can be injected via syringe.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!